Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Finance In Brief

This article was originally published in The Rose Sheet

Executive Summary

J&J Q3: U.S. consumer sales were $1.14 bil. in the third quarter, representing an increase of 5.9% over the prior-year period, Johnson & Johnson announces Oct. 17. Worldwide consumer sales were $2.46 bil., an increase of 10.1% over the prior year, boosted in part by the international growth of skin care products primarily reflecting the recent acquisition of French skin care marketer Groupe Vendome (1"The Rose Sheet" March 27, 2006, In Brief). The sales performance included a 2% positive impact from currency...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS014295

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel